Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Ewing 1Recurrence 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm Metastasis 1Hematopoietic and Lymphoid System Neoplasm 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 5regorafenib 3Temozolomide 3Magnetic Resonance Spectroscopy 3Irinotecan 3Etoposide 3Doxorubicin 3ulixertinib 2tipifarnib 2selpercatinib 2palbociclib 2ivosidenib 2etoposide phosphate 2cabozantinib 2X-Rays 2Vincristine 2Specimen Handling 2Sirolimus 2Radiation 2Phantoms, Imaging 2Nuclear Medicine Department, Hospital 2Ifosfamide 2Biopsy 2tazemetostat 1racemetyrosine 1pembrolizumab 1olaparib 1larotrectinib 1ganitumab 1erdafitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Sarcoma, Ewing × Liquid Biopsy × Clear all
NCT06068075 2026-05-05

Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD

Dana-Farber Cancer Institute

Phase NA Active not recruiting
340 enrolled
Sarcoma

Sarcoma, Ewing, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡